BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24339711)

  • 1. Diagnostic role of prostate resection in the elderly patients who experience significant co-morbidity with a high clinical suspicion of prostate cancer.
    Kang HW; Yang JB; Kwon WA; Lee YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim IY; Kim WJ
    J Korean Med Sci; 2013 Dec; 28(12):1796-800. PubMed ID: 24339711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
    Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
    Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of histological results between resection and biopsy of the prostate].
    Mathieu R; Tibari Y; Verhoest G; Vincendeau S; Manunta A; Rioux-Leclercq N; Bensalah K
    Prog Urol; 2014 May; 24(6):374-8. PubMed ID: 24821561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Accuracy of Transperineal MRI Fusion Biopsy in Comparison to Transrectal Biopsy with Regard to Incidental Histopathological Findings in Transurethral Resection of the Prostate.
    Dieffenbacher SC; Popeneciu IV; Radtke JP; Teber D; Hohenfellner M; Hadaschik BA; Hatiboglu G
    Urol Int; 2017; 99(2):162-167. PubMed ID: 28190012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could the sextant prostate biopsy be replaced by transurethral resection?
    Startsev VY; Pouline I; Gorelov S; Merkulova R
    Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of PSA velocity and PSA density in the prediction of prostate cancer in TURP or open prostatectomy specimen of patients with previous negative prostate biopsy].
    Rodríguez Alonso A; González Blanco A; Barbagelata López A; Pita Fernández S; Suárez Pascual G; Bonelli Martín C; Cuerpo Pérez M
    Actas Urol Esp; 2008 Sep; 32(8):779-86. PubMed ID: 19013975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
    Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
    BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application value of diagnostic TURP for patients with serum PSA abnormality].
    Yuan J; Zhao H; Wu B
    Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL).
    Chung JH; Yu J; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeon SS
    J Korean Med Sci; 2020 Oct; 35(41):e342. PubMed ID: 33107227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
    Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
    Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].
    Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Mikata K; Tuchiya F
    Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):649-59. PubMed ID: 16768146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
    Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
    Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systematic prostate biopsy before transurethral resection of the prostate].
    Hayakawa T; Kanemitsu N; Mitsuya H; Hayase Y; Kojima M
    Nihon Hinyokika Gakkai Zasshi; 2004 Mar; 95(3):588-95. PubMed ID: 15103921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of prostate cancer and death after benign transurethral resection of the prostate-A 20-year population-based analysis.
    Hilscher M; Røder A; Helgstrand JT; Klemann N; Brasso K; Vickers AJ; Stroomberg HV
    Cancer; 2022 Oct; 128(20):3674-3680. PubMed ID: 35975979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer.
    Jin K; Qiu S; Liao XY; Zheng XN; Tu X; Tang LS; Yang L; Wei Q
    Asian J Androl; 2020; 22(2):217-221. PubMed ID: 31210148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.